Citius Oncology, Inc (CTOR) - Margin reged

CTOR (Citius Oncology, Inc) - tandha merek perusahaan

The integration of ESG standards and bioethics into drug development ensures the reliability of Citius Oncology, Inc. (CTOR). The gross profit margin clearly confirms the efficiency trend, where 28.90 determines the current status of the parameter. Physician confidence is growing due to targeted lymphoma treatment methods, although the lack of sales and dependence on external funding create a specific financial inertia for the business.

CTOR Tingkat bathi miturut bathi reged citiusonc.com (14.08.2024 - 20.11.2026)

Rincian analitis lan laporan data perusahaan Citius Oncology (CTOR)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental:CTOR, Citius Oncology Inc.
Produk mawa merek citiusonc.com

To assess the fundamental stability of Citius Oncology, Inc. (CTOR), investors must analyze the efficiency of direct cost management. This gross profit margin measures the profit share after deducting the cost of goods sold, reflecting the recovery speed of operating margins amid turbulence. The high development cost of LYMPHIR and stringent FDA oversight make this indicator critical for confirming the commercial viability of the proprietary asset.

Pesaing utama

Margin bathi reged BeiGene Ltd. (ONC)|Tingkat bathi miturut bathi reged HALO|Rentabilitas reged RVMD|Tingkat bathi miturut bathi reged AAPG (Ascentage)|Tingkat bathi miturut bathi reged cgoncology.com CGON|UroGen Pharma - Tingkat bathi miturut bathi reged|Tingkat bathi reged BCAX|PSNL - Rentabilitas reged|Rentabilitas dodolan miturut bathi reged Erasca Oncology ERAS|delcath.com (DCTH) - Rentabilitas reged|Y-mAbs Therapeutics - Tingkat bathi reged|AURA (Aura Biosciences Inc) - Margin reged|Margin bathi reged candeltx.com CADL|Margin reged ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tingkat bathi reged|Rentabilitas reged Actuate Therapeutics, Inc. ACTU|HURA - Tingkat bathi miturut bathi reged|protaratx.com - Margin reged|FATE - Margin reged|WHWK: Margin reged|TScan Therapeutics (TCRX) - Margin reged|Rentabilitas reged Champions Oncology|Rentabilitas reged XBIT|Margin reged CVM|Tingkat bathi miturut bathi reged OS Therapies Inc. OSTX|Rentabilitas reged Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Margin bathi reged|ANL - Rentabilitas reged|Margin bathi reged verupharma.com|TPST: Margin reged|XLO - Rentabilitas dodolan miturut bathi reged|Rentabilitas reged Renovaro|Margin reged muraloncology.com|Margin reged KAPA|Rentabilitas dodolan miturut bathi reged OnKure Therapeutics, Inc.|Margin reged GDTC (w2.cytomed.sg)|CRIS - Tingkat bathi miturut bathi reged|Apollomics - Margin reged|Tharimmune Corp (THAR) - Tingkat bathi miturut bathi reged|ADVB: Margin reged|Tingkat bathi miturut bathi reged Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Margin reged|Rentabilitas dodolan reged SBFM (Sunshine Biopharma)|Rentabilitas reged Xenetic Bio (XBIO)|Rentabilitas reged SLRX (Salarius Pharma)|Kitov Pharma - Tingkat bathi miturut bathi reged|American Oncology Network (AONC) - Margin bathi reged|BeiGene - Margin reged|Checkpoint Therapeutics, Inc. (CKPT) - Tingkat bathi miturut bathi reged|ELEV (Elevation Oncology, Inc.) - Tingkat bathi miturut bathi reged|iCAD Inc. - Tingkat bathi reged|Tingkat bathi miturut bathi reged IKNA|Margin reged notablelabs.com|Tingkat bathi miturut bathi reged VIRX (Viracta Therapeutics Inc.)|MOR - Margin bathi reged|Rentabilitas reged NAYA Biosciences NAYA|AAPGV - Tingkat bathi miturut bathi reged